Financial statements Fast Pharma
Balance sheet data of FAST PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 644 021,06 | 920 055,25 | 824 313,18 | 1 003 671,72 | 1 284 267,27 | 1 413 233,78 |
| A. Fixed assets | 79 851,75 | 65 266,77 | 52 031,73 | 65 879,17 | 57 012,48 | 68 732,94 |
| B. Current assets | 564 169,31 | 854 788,48 | 772 281,45 | 937 792,55 | 1 227 254,79 | 1 344 500,84 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 644 021,06 | 920 055,25 | 824 313,18 | 1 003 671,72 | 1 284 267,27 | 1 413 233,78 |
| A. Equity | 360 958,90 | 502 687,28 | 567 275,84 | 614 431,11 | 807 009,83 | 880 319,96 |
| B. Liabilities and provisions for liabilities | 283 062,16 | 417 367,97 | 257 037,34 | 389 240,61 | 477 257,44 | 532 913,82 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | 264 829,25 | 398 192,10 | 240 272,60 | 369 141,14 | 443 409,93 | 465 863,19 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.